0 rating

Neuromyelitis Optica

Olfactory dysfunction in neuromyelitis optica spectrum disorders.

Zhang LJ, Zhao N, Fu Y et al.

Tianjin Medical University General Hospital, Tianjin, People’s Republic of China.

 J Neurol 2015;262:1890–8.

Clemens Warnke’s review: Neuromyelitis optica spectrum disorders (NMOSDs) are a group of central nervous inflammatory diseases with clinical and paraclinical features that are distinct from multiple sclerosis (MS). Unlike in MS, autoantigens have been identified in this group of diseases that are of potential pathogenic relevance. Antibodies directed against the water channel aquaporin-4 (AQP-4) characterize the disease as an antibody-mediated astrocytopathy.

Return to top


The Role of B Cells in Multiple Sclerosis: Experimental and Clinical Aspects
Til Menge, MD, Gerd Meyer zu Hörste, MD, and Bernd C Kieseier, MD
CML Multiple Sclerosis
Pharmacogenomics in Multiple Sclerosis
Manuel Comabella, MD and Xavier Montalban, MD
CML Multiple Sclerosis
The Role of MRI as a Predictive Marker for Disease Progression Measured by the Expanded Disability Status Scale
Antonia Ceccarelli, MD, Domenico Caputo, MD, and Marco Rovaris, MD
CML Multiple Sclerosis
Advances in Multiple Sclerosis Therapy: New Oral Disease-Modifying Agents
Andreas Lutterotti, MD and Thomas Berger, MD, MSc
CML Multiple Sclerosis
Optical Coherence Tomography as a Marker of Axonal Damage in Multiple Sclerosis
Shiv Saidha, MRCPI, Christopher Eckstein, MD, and John N Ratchford, MD
CML Multiple Sclerosis